TACC3 and glioblastoma: Fibroblast growth factor receptor (FGFR) gene family alterations, including FGFR3–transforming acidic coiled-coil containing protein 3 (TACC3) fusions, constitute actionable drivers in a subset (3–5%) of GBM, producing fusion proteins that promote oncogenesis [52].